PRPO — Precipio, Inc.

Nasdaq · Unknown · Unknown · CIK 1043961 ·
Last close
$30.85
Market Cap
$55.23M
52W High
$31.50
52W Low
$19.22
ADV30
131,719
Next earnings
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 6,711,000 2,725,000 -1,428,000 -1,443,000 20,803,000 2,604,000 6,636,000
Dec 2025 6,699,000 3,132,000 542,000 526,000 21,317,000 2,651,000 6,756,000
Sep 2025 6,767,000 3,005,000 -61,000 -79,000 21,153,000 2,305,000 7,404,000
Jun 2025 5,654,000 2,429,000 -824,000 74,000 18,816,000 1,130,000 6,528,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$793,000
Investing CF
$-238,000
Financing CF
$1,032,000
CapEx
$-238,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-1.40
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$-104,246,000
Inventory
$870,000
Receivables
$1,988,000
ST Investments
EBIT TTM
$-859,000
Pretax Income TTM
$-922,000
Interest Exp TTM
$63,000
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$27,198,000
EBITDA
$-129,000
Free Cash Flow
$1,346,125
Enterprise Value
$55,740,300
Total Cash
$3,075,000
Total Debt
$3,588,000
Shares Out
1,790,188
Trailing EPS
$-0.61
Book Value
$8.25
ROE
-9.0%
ROA
-4.8%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 24,049,000 -1,202,000 -363,000 21,317,000 6,756,000 685,000
Dec 2024 18,532,000 -4,216,000 -4,290,000 16,996,000 4,902,000 439,000
Dec 2023 15,197,000 -7,620,000 -5,853,000 18,101,000 3,672,000 -3,559,000
Dec 2022 9,412,000 -12,797,000 -12,203,000 21,504,000 5,137,000 -7,721,000

TTM Snapshot

Revenues TTM
$11,485,000
NetIncome TTM
$-13,430,000
OpCashFlow TTM
$0
Assets (Latest)
$842,000
Forward EPS
$0.39

Peers — same industry

TickerNameMarket CapLastDaily %
LOMLF Lion One Metals Ltd. $55.39M $0.14
PGZFF Pan Global Resources Inc. $55.78M $0.14
WSHP WeShop Holdings Ltd $54.66M $4.69
JMM Nuveen Multi-Market Income Fund $54.50M $5.76
BEWFF BEWHERE HOLDINGS INC $54.38M $0.56

News headlines (Yahoo Finance, 1h cache)

PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?
2026-08-24 16:37 · Yahoo
Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record Revenue and Positive EBITDA Mark ...
2026-08-21 03:02 · Yahoo
Precipio Announces Q2-2026 Financial Results
2026-08-14 20:00 · Yahoo
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
2026-06-12 17:00 · Yahoo
Precipio to Present at the Planet MicroCap Las Vegas
2026-06-11 21:00 · Yahoo
Precipio (PRPO) Q1 2026 Earnings Call Transcript
2026-06-02 16:54 · Yahoo
Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges
2026-05-21 01:01 · Yahoo
Precipio Announces Q1 2026 Financial Results
2026-05-14 21:00 · Yahoo
Precipio, Inc. Q2 2026 Earnings Call Summary
2026-08-15 12:30 · Yahoo
PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?
2026-07-16 14:21 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.